Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Nuclear Medicine and Molecular Imaging
Published in: Nuclear Medicine and Molecular Imaging 4/2017

01-12-2017 | Case Report

Unusual Contralateral Axillary Lymph Node Metastasis in a Second Primary Breast Cancer Detected by FDG PET/CT and Lymphoscintigraphy

Authors: Ji-Young Kim, Hyunjong Lee, Tae Sung Kim, Han-Sung Kang, Seok-ki Kim

Published in: Nuclear Medicine and Molecular Imaging | Issue 4/2017

Login to get access

Abstract

Contralateral metastatic axillary lymph nodes in a patient with breast cancer is a rare condition. Here, we present a 55-year-old woman with a second primary breast cancer. The patient underwent 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) for staging work-up. Additionally, preoperative lymphoscintigraphy was performed to detect sentinel lymph nodes. FDG PET/CT demonstrated increased FDG uptake in the left nipple and right axillary lymph nodes. Lymphoscintigraphy identified the right axillary lymph nodes which was consistent with the FDG PET/CT findings. This case emphasizes the usefulness of FDG PET/CT and lymphoscintigraphy for identifying unpredictable contralateral axillary lymph node metastasis from a second primary breast cancer.
Literature
1.
Oh CM, Won YJ, Jung KW, Kong HJ, Cho H, Lee JK, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat. 2016;48:436–50.CrossRefPubMedPubMedCentral
2.
van Maaren MC, de Munck L, Jobsen JJ, Poortmans P, de Bock GH, Siesling S, et al. Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients. Breast Cancer Res Treat. 2016;160:511–21.CrossRefPubMed
3.
Rakha EA, Martin S, Lee AH, Morgan D, Pharoah PD, Hodi Z, et al. The prognostic significance of lymphovascular invasion in invasive breast carcinoma. Cancer. 2012;118:3670–80.CrossRefPubMed
4.
Huston TL, Pressman PI, Moore A, Vahdat L, Hoda SA, Kato M, et al. The presentation of contralateral axillary lymph node metastases from breast carcinoma: a clinical management dilemma. Breast J. 2007;13:158–64.CrossRefPubMed
5.
Son YG, Kim WW, Kim KH, Kim JS, et al. Is it contralateral axillary metastasis or occult breast cancer?: a confusing case report. Case Rep Oncol. 2015;8:498–502.CrossRefPubMedPubMedCentral
6.
Groheux D, Espie M, Giacchetti S, Hindie E. Performance of FDG PET/CT in the clinical management of breast cancer. Radiology. 2013;266:388–405.CrossRefPubMed
7.
Kelemen PR, Lowe V, Phillips N. Positron emission tomography and sentinel lymph node dissection in breast cancer. Clin Breast Cancer. 2002;3:73–7.CrossRefPubMed
8.
Kumar R, Zhuang H, Schnall M, Conant E, Damia S, Weinstein S, et al. FDG PET positive lymph nodes are highly predictive of metastasis in breast cancer. Nucl Med Commun. 2006;27:231–6.CrossRefPubMed
9.
Fehr MK, Hornung R, Varga Z, Burger D, Hess T, Haller U, et al. Axillary staging using positron emission tomography in breast cancer patients qualifying for sentinel lymph node biopsy. Breast J. 2004;10:89–93.CrossRefPubMed
10.
Moncayo VM, Aarsvold JN, Alazraki NP. Lymphoscintigraphy and sentinel nodes. J Nucl Med. 2015;56:901–7.CrossRefPubMed
11.
Morcos B, Jaradat I, El-Ghanem M. Characteristics of and therapeutic options for contralateral axillary lymph node metastasis in breast cancer. Eur J Surg Oncol. 2011;37:418–21.CrossRefPubMed
12.
Boughey JC, Ross MI, Babiera GV, Bedrosian I, Feig BW, Hwang RF, et al. Sentinel lymph node surgery in locally recurrent breast cancer. Clin Breast Cancer. 2006;7:248–53.CrossRefPubMed
13.
14.
Maaskant-Braat AJ, de Bruijn SZ, Woensdregt K, Pijpers H, Voogd AC, Nieuwenhuijzen GA. Lymphatic mapping after previous breast surgery. Breast. 2012;21:444–8.CrossRefPubMed
15.
Roumen RM, Kuijt GP, Liem IH. Lymphatic mapping and sentinel node harvesting in patients with recurrent breast cancer. Eur J Surg Oncol. 2006;32:1076–81.CrossRefPubMed
16.
Tokmak H, Kaban K, Muslumanoglu M, Demirel M, Aktan S. Management of sentinel node re-mapping in patients who have second or recurrent breast cancer and had previous axillary procedures. World J Surg Oncol. 2014;12:205.CrossRefPubMedPubMedCentral
17.
Groheux D, Cochet A, Humbert O, Alberini JL, Hindie E, Mankoff D. 18F-FDG PET/CT for staging and restaging of breast cancer. J Nucl Med. 2016;57(Suppl 1):17S–26S.CrossRefPubMed
18.
Wang W, Yuan P, Wang J, Ma F, Zhang P, Li Q, et al. Management of contralateral axillary lymph node metastasis from breast cancer: a clinical dilemma. Tumori. 2014;100:600–4.PubMed
19.
Moossdorff M, Vugts G, Maaskant-Braat AJ, Strobbe LJ, Voogd AC, Smidt ML, et al. Contralateral lymph node recurrence in breast cancer: regional event rather than distant metastatic disease. A systematic review of the literature. Eur J Surg Oncol. 2015;41:1128–36.CrossRefPubMed
20.
Ucmak Vural G, Sahiner I, Demirtas S, Efeturk H, Demirel BB. Sentinel lymph node detection in contralateral axilla at initial presentation of a breast cancer patient: case report. Mol Imaging Radionucl Ther. 2015;24:90–3.CrossRefPubMedPubMedCentral
Metadata
Title
Unusual Contralateral Axillary Lymph Node Metastasis in a Second Primary Breast Cancer Detected by FDG PET/CT and Lymphoscintigraphy
Authors
Ji-Young Kim
Hyunjong Lee
Tae Sung Kim
Han-Sung Kang
Seok-ki Kim
Publication date
01-12-2017
Publisher
Springer Berlin Heidelberg
Published in
Nuclear Medicine and Molecular Imaging / Issue 4/2017
Print ISSN: 1869-3474
Electronic ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-017-0485-6

Other articles of this Issue 4/2017

Nuclear Medicine and Molecular Imaging 4/2017 Go to the issue

Interesting Image

Usefulness of Tc-99m Pertechnetate SPECT/CT in the Diagnosis of Testicular Infarction After Inguinal Herniorrhaphy

Interesting Image

Microcalcified Hepatic Metastases Incidentally Detected on F-18 NaF PET/CT in a Patient with Prostate Cancer

Original Article

Longitudinal Decline of Striatal Subregional [18F]FP-CIT Uptake in Parkinson’s Disease

Review

Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging in Neurological Diseases

Original Article

68Ga-PSMA PET/CT Imaging Predicting Intraprostatic Tumor Extent, Extracapsular Extension and Seminal Vesicle Invasion Prior to Radical Prostatectomy in Patients with Prostate Cancer

Case Report

Altered Biodistribution of 99mTc-DPD on Bone Scan After Intravenous Iron Supplement